About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in California | 1,207 Studies

Clinical Trials Prostate CancerCalifornia

Prostate Cancer Clinical Trials in California

Find 1,207 clinical trials for prostate cancer near California. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1141-1160 of 1,207 trials

RecruitingAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC)…NCT05939414·Fayetteville, Arkansas and 143 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.A first-in-human clinical trial to test the investigational treatment ONCT-534 in participants with metastatic castration-resistant prostate cancer.NCT05917470·San Francisco, California and 9 others

CompletedSafety and Tolerability Study Using WST11 In Patients With Localized Prostate CancerThe aim of this study is to determine the optimal treatment conditions (WST11 dose and light energy dose) to achieve ablation in one lobe of the prostate and to evaluate the…NCT00946881·Los Angeles, California and 4 others

RecruitingStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant…NCT06136624·Orange, California and 287 others

WithdrawnIpilimumab and GMCSF Immunotherapy for Prostate CancerThis is an open-label randomized phase II study. Patients are randomized so as to achieve uniform patient cohorts treated on each regimen.NCT01530984·San Francisco, California

CompletedMR Guided Focused Ultrasound Surgery of Metastatic Bone TumorsThe objective of this trial is to evaluate the safety and effectiveness of MRgFUS in the treatment of metastatic bone tumors.NCT00350233·La Jolla, California and 1 other

TerminatedP-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC and SGC.NCT04249947·Duarte, California and 9 others

CompletedMolecular Urine Tests for Prostate CancerProstate cancer is the second leading cause of cancer related deaths among men in the United States.1 Although still controversial, there is growing evidence that early detection…NCT00581516·Orange, California

RecruitingEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsThe objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and…NCT05983432·Beverly Hills, California and 36 others

Approved for marketing18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate CancerThe purpose of this research study is to see if patients' tumor can be identified by 18F-DCFPyL PET/MRI scan.NCT04809584·Stanford, California

WithdrawnNutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate CancerThis trial studies nutritional preferences and product accessibility in oral nutritional supplements in participants with breast, colorectal, upper gastrointestinal, or prostate…NCT03563352·Los Angeles, California

TerminatedNeoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate CancerThis is a multicentered, open label, randomized phase II trial of PROSTVAC or ipilimumab or the combination of PROSTVAC and ipilimumab as neoadjuvant therapy in patients with…NCT02506114·San Francisco, California

UnknownPatient-Centered Communication of Life Expectancy Estimates in Genitourinary MalignanciesInvestigators will conduct a randomized trial to determine if providing patient-specific life expectancy estimates during treatment counseling via a targeted, patient-centered…NCT03522155·Los Angeles, California

CompletedSodium Selenite and Radiation Therapy in Treating Patients With Metastatic CancerThe purpose of this study is to determine the maximum-tolerated dose (MTD) of sodium selenite when administered in combination with radiation therapy to subjects with metastatic…NCT02184533·Stanford, California

Active not recruitingPlant-based Diets and Risk of Cancer in the Adventist Health Study-2The Adventist Health Study-2 is a long-term study, exploring the links between lifestyle, diet, and disease outcomes among Seventh-day Adventists.NCT03615599·Loma Linda, California

CompletedA Study of Intra-operative Autologous Retropubic Urethral Sling on Urinary Control After Robot Assisted Radical ProstatectomyPlacement of an autologous retropubic urethral sling at the time of robot assisted radical prostatectomy will improve the recovery of continence after radical prostatectomyNCT01821209·San Francisco, California

RecruitingA Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)This study will assess the safety and tolerability of valemetostat in combination with darolutamide in participants with Metastatic Castration Resistant Prostate Cancer (mCRPC).NCT07244341·La Jolla, California and 18 others

CompletedProspective Assessment of Image Registration for the Diagnosis of Prostate CancerThis is a pilot study to determine cancer detection rate of conventional/systematic versus targeted biopsy methods in diagnosis of potentially lethal prostate cancer.NCT02425228·Los Angeles, California and 1 other

RecruitingStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesThis study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer…NCT05417594·La Jolla, California and 31 others

RecruitingPositron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyThe aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.NCT06056830·Birmingham, Alabama and 33 others

PreviousPage 58 of 61Next

Other Conditions in California

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma